<DOC>
	<DOCNO>NCT00165490</DOCNO>
	<brief_summary>The purpose study find effect ( good bad ) combination three chemotherapy drug ( cetuximab , cisplatin , irinotecan ) esophageal cancer give radiation therapy .</brief_summary>
	<brief_title>Combination Chemotherapy , Radiation Therapy Surgery Esophageal Cancer</brief_title>
	<detailed_description>- Patients participate study must tumor biopsy take confirm type tumor . - Outpatient therapy cetuximab alone give intravenously week 0 . - During week 1-8 outpatient radiation therapy start continued per day 28 treatment 5 1/2 week . - Outpatient chemotherapy ( cisplatin , irinotecan cetuximab ) give per week week 1 , 2 , 4 , 5 . Cetuximab alone give week 3 , 6 , 7 , 8 . - A repeat CT scan PET scan perform restage tumor week 8 . This confirm cancer remain localize . - Inpatient surgery schedule 4 8 week completion chemotherapy radiation therapy . - Cetuximab restart within 4 week surgery continue weekly 6 month . - During chemotherapy radiation therapy , physical exam vital sign perform chemotherapy treatment . Routine blood test also perform . - Between chemotherapy-radiation therapy surgery CAT scan chest , abdomen pelvis along PET scan perform . - After surgery CAT scan chest , abdomen pelvis perform every 3 month 2 year every 6 month 3 year . An EGD ( upper endoscopy ) biopsy do every 6 month 2 year yearly 3 year . Physical exam , vital sign routine blood test do every 2 week 6 month , every 3 month 1.5 year , every 6 month 3 year .</detailed_description>
	<mesh_term>Carcinoma , Squamous Cell</mesh_term>
	<mesh_term>Adenocarcinoma</mesh_term>
	<mesh_term>Esophageal Neoplasms</mesh_term>
	<mesh_term>Irinotecan</mesh_term>
	<mesh_term>Cisplatin</mesh_term>
	<mesh_term>Cetuximab</mesh_term>
	<criteria>18 year age older Negative pregnancy test Adenocarcinoma squamous cell carcinoma esophagus , include gastroesophageal junction , histologically confirm , stage IIA , IIB III . ECOG performance status 0 1 . Neutrophils great equal 1,500/ul Platelets great equal 100,000/ul Serum bilirubin less equal 1.5mg/ul Serum creatinine less equal 1.5mg/ul AST SGOT less equal 2.5x upper normal limit Alkaline phosphatase less equal 5x upper normal limit Prior surgery esophageal gastroesophageal junction cancer . Prior chemotherapy radiation therapy Biopsy proven tumor invasion tracheobronchial tree tracheoesophageal fistula . Metastatic disease distant organs nonregional lymph node . Comorbid disease opinion investigator make combine chemoradiotherapy inadvisable . Pregnant lactating woman Other active malignancy Patients know Gilbert 's Disease interstitial pulmonary fibrosis . History seizure disorder Uncontrolled diarrhea Peripheral neuropathy ( Grade 2 ) Prior cetuximab therapy specifically directly target EGF pathway .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2014</verification_date>
	<keyword>adenocarcinoma esophagus</keyword>
	<keyword>squamous cell carcinoma esophagus</keyword>
	<keyword>combination chemotherapy</keyword>
	<keyword>cisplatin</keyword>
	<keyword>irinotecan</keyword>
	<keyword>radiation therapy</keyword>
	<keyword>resectable esophageal cancer</keyword>
</DOC>